These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38457290)

  • 1. Dehydrated human amnion/chorion membrane to treat venous leg ulcers: a cost-effectiveness analysis.
    Tettelbach WH; Driver V; Oropallo A; Kelso MR; Niezgoda JA; Wahab N; Jong JL; Hubbs B; Forsyth RA; Magee GA; Steel P; Cohen BG; Padula WV
    J Wound Care; 2024 Mar; 33(Sup3):S24-S38. PubMed ID: 38457290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of dehydrated human amnion/chorion membrane allografts in lower extremity diabetic ulcer treatment.
    Tettelbach WH; Armstrong DG; Chang TJ; Jong JL; Glat PM; Hsu JH; Kelso MR; Niezgoda JA; Labovitz JM; Hubbs B; Forsyth RA; Cohen BG; Reid NM; Padula WV
    J Wound Care; 2022 Feb; 31(Sup2):S10-S31. PubMed ID: 35148642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of Compression Therapy With Early Endovenous Ablation in Venous Ulceration for a Medicare Population.
    Zheng H; Magee GA; Tan TW; Armstrong DG; Padula WV
    JAMA Netw Open; 2022 Dec; 5(12):e2248152. PubMed ID: 36542379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential cost-effectiveness of using adjunctive dehydrated human amnion/chorion membrane allograft in the management of non-healing diabetic foot ulcers in the United Kingdom.
    Guest JF; Atkin L; Aitkins C
    Int Wound J; 2021 Dec; 18(6):889-901. PubMed ID: 33827144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment patterns and outcomes of Medicare enrolees who developed venous leg ulcers.
    Tettelbach WH; Driver V; Oropallo A; Kelso MR; Niezgoda JA; Wahab N; De Jong JL; Hubbs B; Forsyth RA; Magee GA
    J Wound Care; 2023 Nov; 32(11):704-718. PubMed ID: 37907359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A confirmatory study on the efficacy of dehydrated human amnion/chorion membrane dHACM allograft in the management of diabetic foot ulcers: A prospective, multicentre, randomised, controlled study of 110 patients from 14 wound clinics.
    Tettelbach W; Cazzell S; Reyzelman AM; Sigal F; Caporusso JM; Agnew PS
    Int Wound J; 2019 Feb; 16(1):19-29. PubMed ID: 30136445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain reduction by dehydrated human amnion/chorion membrane allograft in nondiabetic leg ulcers might be an early indicator of good response: A case series.
    Mueller SM; Navarini AA; Itin P; Schwegler S; Laeuchli S; Goldust M; Ivanova K
    Dermatol Ther; 2020 Jul; 33(4):e13587. PubMed ID: 32410269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in study outcomes relative to intention-to-treat and per-protocol data analysis techniques in the evaluation of efficacy for treatment of venous leg ulcers with dehydrated human amnion/chorion membrane allograft.
    Bianchi C; Tettelbach W; Istwan N; Hubbs B; Kot K; Harris S; Fetterolf D
    Int Wound J; 2019 Jun; 16(3):761-767. PubMed ID: 30864259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dehydrated human amnion/chorion membrane treatment of venous leg ulcers: correlation between 4-week and 24-week outcomes.
    Serena TE; Yaakov R; DiMarco D; Le L; Taffe E; Donaldson M; Miller M
    J Wound Care; 2015 Nov; 24(11):530-4. PubMed ID: 26551645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological properties of dehydrated human amnion/chorion composite graft: implications for chronic wound healing.
    Koob TJ; Rennert R; Zabek N; Massee M; Lim JJ; Temenoff JS; Li WW; Gurtner G
    Int Wound J; 2013 Oct; 10(5):493-500. PubMed ID: 23902526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Properties of dehydrated human amnion/chorion composite grafts: Implications for wound repair and soft tissue regeneration.
    Koob TJ; Lim JJ; Massee M; Zabek N; Denozière G
    J Biomed Mater Res B Appl Biomater; 2014 Aug; 102(6):1353-62. PubMed ID: 24664953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydrated human amnion/chorion membrane regulates stem cell activity in vitro.
    Massee M; Chinn K; Lei J; Lim JJ; Young CS; Koob TJ
    J Biomed Mater Res B Appl Biomater; 2016 Oct; 104(7):1495-503. PubMed ID: 26175122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Cost-Effectiveness Analysis Comparing Single-use and Traditional Negative Pressure Wound Therapy to Treat Chronic Venous and Diabetic Foot Ulcers.
    Kirsner RS; Delhougne G; Searle RJ
    Wound Manag Prev; 2020 Mar; 66(3):30-36. PubMed ID: 32294054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and cost efficacy of advanced wound care matrices for venous ulcers.
    Hankin CS; Knispel J; Lopes M; Bronstone A; Maus E
    J Manag Care Pharm; 2012 Jun; 18(5):375-84. PubMed ID: 22663170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dehydrated human amnion/chorion membrane allografts for myelomeningocele and wound reconstruction.
    Chen J; Lopez CD; Girard AO; Abousy M; Redett RJ; Groves M; Yang R
    Childs Nerv Syst; 2021 Dec; 37(12):3721-3731. PubMed ID: 34609611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost effectiveness analysis for commonly used human cell and tissue products in the management of diabetic foot ulcers.
    Nherera LM; Banerjee J
    Health Sci Rep; 2024 Mar; 7(3):e1991. PubMed ID: 38524772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and cost efficacy of advanced wound care matrices in the treatment of venous leg ulcers: a systematic review.
    Massand S; Lewcun JA; LaRosa CA
    J Wound Care; 2021 Jul; 30(7):553-561. PubMed ID: 34256600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Dehydrated Human Amnion/Chorion Membrane Allografts in More Than 100 Patients with Six Major Types of Refractory Nonhealing Wounds.
    Garoufalis M; Nagesh D; Sanchez PJ; Lenz R; Park SJ; Ruff JG; Tien A; Goldsmith J; Seat A
    J Am Podiatr Med Assoc; 2018 Mar; 108(2):84-89. PubMed ID: 29634297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dehydrated human amnion and chorion allograft versus standard of care alone in treatment of Wagner 1 diabetic foot ulcers: a trial-based health economics study.
    Carter MJ
    J Med Econ; 2020 Nov; 23(11):1273-1283. PubMed ID: 32729342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An evaluation of dehydrated human amnion/chorion membrane allografts for pressure ulcer treatment: a case series.
    Berhane CC; Brantley K; Williams S; Sutton E; Kappy C
    J Wound Care; 2019 May; 28(Sup5):S4-S10. PubMed ID: 31067170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.